Illumina Ventures
Venture capital firm · Founded 2016 · San Francisco, CA · San Francisco ↗
Independent venture firm focused on genomics and precision health investing, building the ecosystem that translates investment into innovation in human health.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Illumina Ventures, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$560M
Latest fund
Illumina Innovation Fund II, L.P.$325M · 2021
Funds
2
Check size
LAST CHECKED NOV 2026
Stages
SeedSeries A
Sectors
genomicsprecision healthlife sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Twist BioscienceIPO (Nasdaq: TWST)
Illumina Ventures' Fund II close release lists Twist Bioscience (Nasdaq: TWST) among the firm's portfolio companies; Twist went public in 2018.
Source: illuminaventures.com
Misses
Track record
Partners 4
- Arnaud Autret
Principal & Head of European Operations
Board seats
No public record - Nick Naclerio
Founding Partner
Board seats
No public record - Wouter Meuleman
Partner
Board seats
No public record - Charles Lin
Principal
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- PitchBook profile
pitchbook.com
- Global Corporate Venturing: Fund II
globalventuring.com
Contact
Published sources only
Published contact
- Website
- www.illuminaventures.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Illumina Ventures. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Sector-specialist genomics investor; fetched homepage publishes no AUM or fund size, so no higher tier rule fires. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Illumina Ventures — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation
- [2]
FIRM SITE · Illumina Ventures — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
